Arthritis Therapy Alexandria LA

Local resource for arthritis therapy in Alexandria. Includes detailed information on local businesses that provide access to arthritis pain relief, arthritis medication, arthritis natural treatments, rheumatoid arthritis treatments, physical therapy, and occupational therapy, as well as advice and content on arthritis surgery.

Mohammad Shbeeb
(318) 767-8393
3349 Masonic Dr
Alexandria, LA
Specialty
Internal Medicine, Rheumatology

Data Provided By:
Miguel A Garcia Caro, MD
(318) 445-9331
1337 Centre Ct
Alexandria, LA
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Univ Of Pr Sch Of Med, San Juan Pr 00936
Graduation Year: 1981

Data Provided By:
Agnes A Solon Ashby, MD
(312) 567-2000
Alexandria, LA
Specialties
Internal Medicine, Rheumatology
Gender
Female
Education
Medical School: Univ Of The Philippines, Coll Of Med, Manila, Philippines
Graduation Year: 1987

Data Provided By:
Robert Emory Goodman, MD
(318) 424-9240
740 Jordan St
Shreveport, LA
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: La State Univ Sch Of Med In Shreveport, Shreveport La 71130
Graduation Year: 1980

Data Provided By:
Elizabeth Marie Adams, MD
(301) 657-9804
4740 S I 10 Service Rd W Fl 2
Metairie, LA
Specialties
Internal Medicine, Rheumatology
Gender
Female
Education
Medical School: Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298
Graduation Year: 1985

Data Provided By:
Agnes A Solon
(318) 442-4200
201 4th St
Alexandria, LA
Specialty
Rheumatology

Data Provided By:
Mohammad I Shbeeb, MD
(318) 767-8393
3349 Masonic Dr
Alexandria, LA
Specialties
Internal Medicine, Rheumatology
Gender
Male
Education
Medical School: Univ Of Jordan, Fac Of Med, Amman, Jordan
Graduation Year: 1987

Data Provided By:
Miguel Angel Garcia-Caro
(318) 445-9331
1337 Centre Ct
Alexandria, LA
Specialty
Rheumatology

Data Provided By:
Mittie Kelleher Doyle, MD
New Orleans, LA
Specialties
Internal Medicine, Rheumatology
Gender
Female
Education
Medical School: Yale Univ Sch Of Med, New Haven Ct 06510
Graduation Year: 1990

Data Provided By:
Elena C Cucurull, MD
7373 Perkins Rd
Baton Rouge, LA
Specialties
Internal Medicine, Rheumatology
Gender
Female
Education
Medical School: Univ De Barcelona, Fac De Med, Barcelona, Spain
Graduation Year: 1990

Data Provided By:
Data Provided By:

New, Targeted Therapies for Arthritis

There are many different types of rheumatological diseases. A rheumatological disease is an inflammatory arthritis that affects the entire body as a whole. Rheumatoid arthritis (RA) is the most common rheumatologic disease. Certain types of rheumatoid arthritis seem to target specific joints.

When a rheumatological disease affects the spine, the resulting conditon is called a spondyloarthropathy. The term is made up of Greek words: Spondylo means vertebra, arthro means joint and pathos means disease. When other more peripheral joints are affected (such as in the arms and legs), the rheumatologic arthritis is referred to as an spondyloarthritide.

In this article, Dr. Philip J. Mease from the Division of Rheumatology, University School of Medicine in Seattle, Washington gives us an update on two of the more common spondyloarthropathies: psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Psoriatric arthritis affects the peripheral joints. Ankylosing spondylitis affects the spine.

New findings in the field have brought these conditions and their treatment to our attention. The first major breakthrough in understanding and treating these diseases is in the area of pathophysiology. Pathophysiology tells us what went wrong at the cellular level to cause these problems.

Researchers are identifying specific differences between rheumatoid arthritis and spondyloarthropathies. Their work in the field of osteoimmunology is helping determine what's going on between the bone cells (osteo) and the immune system. This knowledge has led to more refined development of specific drug treatments for these two types of arthritis. That's good news for anyone suffering from any kind of rheumatologic disease.

For example, MRIs of patients with spondyloarthropathies show bone edema before any actual bone damage occurs in the joints. At the same time, they have found nests of lymphocytes (white blood cells), bone cells, and blood in the bone marrow (inside bones) of patients with ankylosing spondylitis. Though the exact meaining of these findings are unknown, they point in a direction to help drug manufacturers develop medications that could stop this process.

Measuring the effect of therapy on disease activity is one way to assess new treatments. Studies look at before and after outcomes of therapy on affected joints, skin, pain, function, fatigue, and quality of life. The therapeutic effects of treatment on disease activity can be difficult to measure -- especially when those changes occur at the cellular level. MRIs and X-rays may be helpful.

Patient-reported outcomes using various surveys can help track patient perceived changes, too. Some of these tools include the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Function Index (BASFI), and the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire.

Standard treatment of mild spondyloarthropathies start...

Click here to read the rest of this article from eOrthopod.com